Recombinant Human BDNF Biotinylated Protein, CF

R&D Systems, part of Bio-Techne | Catalog # BT11166

Biotinylated
R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
BT11166-025
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

CHO

Accession #

P23560.1

Structure / Form

Biotinylated via amines

Conjugate

Biotin

Applications

Bioactivity

View all BDNF Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human BDNF protein
His129-Arg247

Purity

>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

His129

Predicted Molecular Mass

13.5 kDa

SDS-PAGE

11-16 kDa, under reducing conditions.

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human TrkB Fc Chimera (Catalog # 688-TK) is immobilized at 0.5 μg/mL (100 μL/well), Biotinylated Recombinant Human BDNF (Catalog # BT11166) binds with an ED50 of 1.00-10.0 ng/mL.

Scientific Data Images for Recombinant Human BDNF Biotinylated Protein, CF

Biotinylated Recombinant Human BDNF Protein Binding Activity.

Measured by its binding ability in a functional ELISA. When Recombinant Human TrkB Fc Chimera (688-TK) is immobilized at 0.5 μg/mL (100 μL/well), Biotinylated Recombinant Human BDNF Protein (Catalog # BT11166) binds with an ED50 of 1.00-10.0 ng/mL

Formulation, Preparation and Storage

BT11166
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: BDNF

Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of growth factors that are required for the differentiation and survival of specific neuronal subpopulations in both the central as well as the peripheral nervous system. The neurotrophin family is comprised of at least four proteins including BDNF, nerve growth factor (NGF), neurotrophin-3 (NT3), and NT4/5. Human BDNF is initially expressed as a proprotein, which is then cleaved to yield a mature protein. Mature BDNF is a non-covalently linked homodimer, with each monomer containing antiparallel beta-strands and a characteristic cystine knot motif. Within the mature domain, human BDNF shares the identical amino acid sequence with mature mouse and rat BDNF. BDNF is strongly expressed in various regions of the brain, including the hippocampus and cerebellum, and weaker expression has been detected in the thymus, liver, spleen, heart, and lung. BDNF participates in axonal growth and pathfinding and in the modulation of dendritic growth and morphology and in later stages of development regulates synaptic transmission and plasticity and acts as a central modulator of pain. BDNF binds with high affinity and specifically activates the TrkB tyrosine kinase receptor. BDNF signaling via TrkB is essential for adult synaptic plasticity and the formation of memories. The BDNF signaling pathway utilizes both AKT and ERK pathways to exert its pleiotrophic effects in the central nervous system. Decreased expression of BDNF is seen in many neurological diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and autism. Further, BDNF is proposed as a biomarker for psychiatric disorders such as bipolar disease and depression and has been implicated in posttraumatic stress disorder, phobia, and panic disorder. A single amino acid substitution, Val66Met, has been shown to lead to reduced, activity-dependent BDNF secretion and memory impairment.

References

  1. Numakawa, T. et al. (2010) Histol. Histopathol. 25:237.
  2. Egan, M.F. et al. (2003) Cell 112:257.
  3. Pruunsild, P. et al. (2007) Genomics 90:397.
  4. Bathina, S. and Das, U.N. (2015) AMS 11:1164.
  5. Binder, D.K. and Scharfman, H.E.(2004) Growth Factors 22:123.
  6. Cattaneo, A. et al. (2016) Transl. Psychiatry 6:e958.
  7. Andero, R. et al. (2011) Am J. Psychiatry 168:163.

Long Name

Brain-derived Neurotrophic Factor

Alternate Names

Abrineurin, ANON2, BULN2, Neurotrophin

Entrez Gene IDs

627 (Human); 12064 (Mouse); 24225 (Rat)

Gene Symbol

BDNF

UniProt

P23560.1

Additional BDNF Products

Product Documents for Recombinant Human BDNF Biotinylated Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human BDNF Biotinylated Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.